These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10117635)

  • 1. Hospital pharmacies watch prescriptions as debate rages over 'off-label' drug use.
    Wagner M
    Mod Healthc; 1992 May; 22(19):62. PubMed ID: 10117635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From off-label prescribing towards a new FDA.
    Tabarrok A
    Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
    Joseph JN; Deaton D; Ehsan H; Bonanno MA
    J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use.
    Meadows WA; Hollowell BD
    Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic agents: comparing off-label uses among authoritative drug compendia.
    Thompson DF; Keefe CC
    Hosp Formul; 1993 Jul; 28(7):641-2, 647. PubMed ID: 10127046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outpatient pharmacy services benefit in a reformed health care system. Coalition for Consumer Access to Pharmaceutical Care.
    Am J Hosp Pharm; 1993 Jul; 50(7):1464-6. PubMed ID: 8362885
    [No Abstract]   [Full Text] [Related]  

  • 7. Economics of institutional pharmacy services under national health insurance in Australia.
    Brooks GE; Knapp DA
    Am J Hosp Pharm; 1975 Oct; 32(10):1018-22. PubMed ID: 1190213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bar coding: old technology to the rescue.
    Ochs J
    Manag Care; 2003 Jun; 12(6):46-7. PubMed ID: 12854261
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
    Kocs D; Fendrick AM
    Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract]   [Full Text] [Related]  

  • 13. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. View from the Nation's Capital. "Off-label" uses of approved drugs: limits on physicians' prescribing behavior.
    Appler WD; McMann GL
    J Clin Psychopharmacol; 1989 Oct; 9(5):368-70. PubMed ID: 2794099
    [No Abstract]   [Full Text] [Related]  

  • 15. Off-label Rx. Insurers starting to balk.
    Higgins LC
    Med World News; 1988 Oct; 29(20):22-4, 26, 31-2. PubMed ID: 10290171
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label prescribing of drugs in specialty headache practice.
    Loder EW; Biondi DM
    Headache; 2004; 44(7):636-41. PubMed ID: 15209684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are "off-labels" legal?
    Price EC
    Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of factors influencing antibiotic usage in hospitals.
    Sabath LD; Notto DA
    Prog Clin Biol Res; 1979; 35():65-74. PubMed ID: 538037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.